Out of the six breast cancer cell lines, three were chosen for further analysis (one from each breast cancer subtype, namely MDA-MB-453 (HER2+), MCF7 (ER+ /PR+), and MDA-MB-231 (TNBC)). Here, ERBB2 is linked to breast carcinoma.